CEO Kevin Smith told investors at the KeyBanc Conference that the company has spent the past two years stabilizing operations ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company ...

We are thrilled to have appointed Gregoire Ramade as Chief Commercial Officer in January. Greg's experience will help improve Inogen's products, commercial strategy and customer experience. We also ...

Inogen, Inc. INGN has been gaining on the back of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a strong product portfolio ...

Inogen’s latest earnings call struck an optimistic tone, highlighting a company in the midst of a strategic turnaround. Management emphasized rising volumes, improving profitability metrics and a ...

In January, Koninklijke Philips NV (NYSE:PHG) announced that it would stop selling new CPAP or BiPAP sleep therapy devices or other respiratory care devices in the U.S. until the consent decree’s ...

Welcome to Inogen’s First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded today ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a ...